Low-dose radiotherapy for COVID-19 pneumonia: A possible low-cost treatment option for immunomodulation
Main Authors: | Namrata Das, Kannan Periasamy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Cancer Research, Statistics, and Treatment |
Online Access: | http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=4;spage=830;epage=832;aulast=Das |
Similar Items
-
Low-Dose Radiotherapy for Late-Stage COVID-19 Pneumonia?
by: Michael I. Koukourakis
Published: (2020-09-01) -
Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment
by: Pedro C. Lara, et al.
Published: (2020-07-01) -
Low dose anti-inflammatory radiotherapy for the treatment of pneumonia by covid-19: A proposal for a multi-centric prospective trial
by: M. Algara, et al.
Published: (2020-09-01) -
Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art
by: Yinhua Zhang, et al.
Published: (2020-11-01) -
Immunomodulation Through Low-Dose Radiation for Severe COVID-19: Lessons From the Past and New Developments
by: Yannic N. Hanekamp, et al.
Published: (2020-09-01)